论文部分内容阅读
目的:探讨丁苯酞与依达拉奉配伍治疗急性脑梗死的临床疗效。方法:将60例急性脑梗死患者随机分为治疗组(30例)和对照组(30例),两组患者入院后均予以相同的基础治疗,治疗组给予丁苯酞与依达拉奉治疗,对照组单独给予依达拉奉治疗,均治疗14d,比较两组患者的临床疗效。结果:经过14d的治疗后,治疗组总有效率为90.0%,对照组总有效率为56.7%;治疗组SSS评分明显优于对照组(P<0.05)。结论:丁苯酞与依达拉奉配伍治疗急性脑梗死可快速明显的改善神经功能,无明显不良反应。
Objective: To investigate the clinical efficacy of butylphthalide and edaravone in the treatment of acute cerebral infarction. Methods: Sixty patients with acute cerebral infarction were randomly divided into treatment group (30 cases) and control group (30 cases). Both groups were given the same basic treatment after admission. Butylphthalide and edaravone , The control group were treated with edaravone alone, were treated 14d, the clinical efficacy of two groups were compared. Results: After 14 days of treatment, the total effective rate was 90.0% in the treatment group and 56.7% in the control group. The SSS score of the treatment group was significantly better than that of the control group (P <0.05). Conclusion: The combination of butylphthalide and edaravone in the treatment of acute cerebral infarction can quickly and obviously improve the neurological function without obvious adverse reactions.